U.S. Reviews CBD Amid Pressure to Act Quickly
- Agency may limit how much can be included in food and drinks
- Market for pot compound estimated to be $15 billion in 5 years
This article is for subscribers only.
The U.S. Food and Drug Administration will hold its first public hearing Friday into how it should regulate CBD products, and it may end up limiting how much of the cannabis compound can be included in food and drinks.
Cannabidiol, the formal name for CBD, is rapidly becoming a hot wellness trend following the legalization of hemp in the U.S. in December. Mainstream retailers like CVS Health Corp. already sell CBD creams, sprays and lotions but the substance hasn’t yet been approved for use in food and drinks by the FDA. Unlike its cousin THC, CBD doesn’t give users a high. Instead, it’s pitched as a natural way to fight ailments like insomnia, inflammation and anxiety.